Government commercialised ayurvedic medicines for diabetes, arthritis

Published On 2017-08-08 03:52 GMT   |   Update On 2017-08-08 03:52 GMT
New Delhi: Minister of State (Independent Charge) for AYUSH, Shri Shripad Yesso Naik in written reply to a question in Lok Sabha has informed that two important drugs developed by the Central Council for Research in Ayurvedic Sciences (CCRAS) have been commercialised.


Drugs by the name AYUSH 82 commercialized for Type II Diabetes Mellitus and AYUSH SG for rheumatoid arthritis said Shripad Naik.


He also informed that Central Council for Research in Siddha (CCRS) has filed for patent D5 Chooranam, a drug for Diabetes Mellitus


The Central Council for Research in Homoeopathy (CCRH) has developed Drugs like Coleus forskohlii, Catharanthus roseus, Cyclosporinum, Azathioprium, Buxus sempervirens, Cynara scolymus, Persea americana, and Withania somnifera.


Central Council for Research in Unani Medicine (CCRUM) has filled Patents for five Unani drugs on filariasis, hepatitis, ulcer, vitiligo and malaria.


"In addition, the Council of Scientific & Industrial Research (CSIR) also conducts research for development of herbal drugs and formulations. It has developed BGR-34 for diabetes, Risorine for tuberculosis and anti-arthritis formulation for osteoarthritis," Naik added.



Article Source : with inputs from IANS

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News